A Study of the Tolerability, Safety, and Pharmacokinetics of ISU302 in Healthy Volunteers

Clinical trial NCT01881633 · COMPLETED

Trial details

NCT number: NCT01881633
Sponsor: ISU Abxis Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gaucher Disease

Start date: 2010-10-01
Primary completion: 2010-11-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.